E-LIB Suche - Ergebnisse für: Ramasamy, Maheshi N

1

Synbiotics in post-acute COVID-19 syndrome—a potential new ..:

Raman, Betty ; Ramasamy, Maheshi N
The Lancet Infectious Diseases. 24 (2024) 3 - p. 219-221 , 2024

Link: https://doi.org/10.1016/..

2

Immunogenicity and safety of beta variant COVID-19 vaccine ..:

Costa Clemens, Sue Ann ; Jepson, Brett ; Bhorat, Qasim E...
The Lancet Microbe. , 2024

Link: https://doi.org/10.1016/..

3

The 2022 Vaccines Against Shigella and Enterotoxigenic Esch..:

Baqar, Shahida ; Bonavia, Aurelio ; Louis Bourgeois, A....
Vaccine. 42 (2024) 7 - p. 1445-1453 , 2024

Link: https://doi.org/10.1016/..

4

Immunogenicity and safety of AZD2816, a beta (B.1.351) vari..:

Ramasamy, Maheshi N ; Kelly, Elizabeth J ; Seegobin, Seth...
The Lancet Microbe. 4 (2023) 11 - p. e863-e874 , 2023

Link: https://doi.org/10.1016/..

5

Accelerating clinical development of a live attenuated vacc..:

McCann, Naina ; Emary, Katherine ; Singh, Nisha...
BMJ Open. 13 (2023) 5 - p. e068966 , 2023

Link: https://doi.org/10.1136/..

6

Persistence of immune response in heterologous COVID vaccin..:

Shaw, Robert H. ; Greenland, Melanie ; Stuart, Arabella S.V....
Journal of Infection. 86 (2023) 6 - p. 574-583 , 2023

Link: https://doi.org/10.1016/..

7

Persistence of the immune response after two doses of ChAdO..:

Voysey, Merryn ; Flaxman, Amy ; Aboagye, Jeremy...
Clinical and Experimental Immunology. 211 (2023) 3 - p. 280-287 , 2023

Link: https://doi.org/10.1093/..

8

The iNTS-GMMA vaccine: a promising step in non-typhoidal Sa..:

Skidmore, Peter D ; Canals, Rocio ; Ramasamy, Maheshi N
Expert Review of Vaccines. 22 (2023) 1 - p. 918-920 , 2023

Link: https://doi.org/10.1080/..

9

Complications and mortality of non-typhoidal salmonella inv..:

Marchello, Christian S ; Birkhold, Megan ; Crump, John A...
The Lancet Infectious Diseases. 22 (2022) 5 - p. 692-705 , 2022

Link: https://doi.org/10.1016/..

10

Effect of priming interval on reactogenicity, peak immunolo..:

Shaw, Robert H ; Liu, Xinxue ; Stuart, Arabella S V...
The Lancet Respiratory Medicine. 10 (2022) 11 - p. 1049-1060 , 2022

Link: https://doi.org/10.1016/..

11

Booster Vaccination Against SARS-CoV-2 Induces Potent Immun..:

Fidler, Sarah ; Fox, Julie ; Tipoe, Timothy...
Clinical Infectious Diseases. 76 (2022) 2 - p. 201-209 , 2022

Link: https://doi.org/10.1093/..

12

CoronaVac: more data for regulators and policy makers:

Ramasamy, Maheshi N ; Jessop, Lucy J
The Lancet. 398 (2021) 10296 - p. 186-188 , 2021

Link: https://doi.org/10.1016/..

13

Different dose regimens of a SARS-CoV-2 recombinant spike p..:

Formica, Neil ; Mallory, Raburn ; Albert, Gary...
PLOS Medicine. 18 (2021) 10 - p. e1003769 , 2021

Link: https://doi.org/10.1371/..

14

Efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-..:

Clemens, Sue Ann Costa ; Folegatti, Pedro M. ; Emary, Katherine R. W....
Nature Communications. 12 (2021) 1 - p. , 2021

Link: https://doi.org/10.1038/..

15

Safety and immunogenicity of heterologous versus homologous..:

Liu, Xinxue ; Shaw, Robert H ; Stuart, Arabella S V...
The Lancet. 398 (2021) 10303 - p. 856-869 , 2021

Link: https://doi.org/10.1016/..